万达生物制药 VNDA 深 沪
等待开盘 11-29 09:30:00 美东时间
5.36
+0.060
+1.13%
华盛通- 最 高5.475
- 今 开5.33
- 成交量 57.65万股
- 最 低 5.30
- 昨 收 5.30
- 总市值 3.17亿
- 52周最高 5.70
- 市盈率 静 --
- 换手率 0.98%
- 52周最低 3.8092
- 委 比 74.96%
- 总股本 5908.91万
- 历史最高 33.44
- 量 比 0.79
- 振 幅 3.30%
- 历史最低 2.92
- 每 手 1
- 风险率 0.33%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多FDA re-review of Vanda tradipitant partial clinical hold extended
The US FDA is extending by a matter of days a re-review of a partial clinical hold on long-term studies of Vanda Pharmaceuticals' (VNDA) tradipitant for motion sickness. The agency was supposed to com...
今天 00:25
FDA Fast-Tracks Vanda's Motion Sickness Drug Review After Leadership Shake-Up
FDA accelerates re-review of Vanda's tradipitant and begins label talks, keeping its motion sickness drug on track for key 2025 decisions.
今天 00:10
Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness
FDA requests, and Vanda agrees to, a brief extension (to December 5, 2025) for the expedited re-review of the partial clinical hold on long-term studies Separately, FDA recently issued label...
11-28 20:00
美股大行评级 | 高盛上调百度、美敦力、晶科能源等多只个股目标价；家得宝遭9家机构下调目标价；
今日重点评级关注：富国银行：维持Annexon"超配"评级，目标价从14美元升至27美元；瑞穗：上调Relmada Therapeutics评级至"跑赢大市"，目标价从1美元升至10美元
11-20 10:28
HC Wainwright & Co. Reiterates Buy on Vanda Pharmaceuticals, Maintains $20 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Vanda Pharmaceuticals (NASDAQ:VNDA) with a Buy and maintains $20 price target.
11-19 19:52
美股牛股 | 嘉楠科技飙升20%，Q3挖矿收入激增241%；Diginex涨超19%，公司与EVIDENT达成战略合作
嘉楠科技飙升20%，Q3营收破1.5亿美元，挖矿收入激增241%；Diginex涨超19%，公司与EVIDENT达成战略合作>>
11-19 16:54
Side Effects From Wegovy? This Vanda Pharmaceuticals' Drug Halves Vomiting In Patients
Vanda Pharmaceuticals' tradipitant successfully reduced Wegovy-induced vomiting by 50% in a clinical trial. Phase 3 anticipated in H1 2026.
11-18 23:49
Vanda's tradipitant can significantly reduce nausea in those taking a GLP-1
A phase 2 trial of Vanda Pharmaceuticals' (VNDA) tradipitant found that the oral therapy tradipitant significantly reduced risk of nausea and vomiting in those taking Novo Nordisk's (NVO) GLP-1 weight...
11-18 22:34
美股大行评级 | 最高325美元！10家机构集体上调AMD目标价；Pinterest遭14家大行下调目标价；大行对优步目标价分歧大，5家下调5家上调
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从3美元升至9美元；HC Wainwright & Co.：上调CervoMed评级至"买入"，目标价从11美元升至25美元
11-06 09:55
美股大行评级 | 最高350美元！16家大行上调谷歌目标价！Meta遭12家大行下调目标价；潜在涨幅1456.29%！NRX Pharmaceuticals获Ascendiant Capital升目标价至47美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从46美元升至47美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从27美元升至31美元
10-31 10:25
